Why would Europe be off limits to Mesoblast for remestemcel-L for aGvHD in paediatric patients?
Cell Therapy News/Articles, page-6770
-
- There are more pages in this discussion • 11,669 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.070(5.02%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $4.800M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 12435 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 6684 | 4 |
View Market Depth
| Last trade - 14.29pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |